Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03269955
What this trial is testing

The Effect of Application of TachoSil® in Pancreatoduodenectomy

Who this might be right for
Pancreatic NeoplasmPancreatic Periampullary CancerPancreatic Bordeline Tumor
Asan Medical Center 126
Not applicableUnknownNCT05593393
What this trial is testing

A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm

Who this might be right for
IPMN, Pancreatic
Peking Union Medical College Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT00201838
What this trial is testing

Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 38
Early research (Phase 1)Study completedNCT03307148
What this trial is testing

Stromal TARgeting for PAncreatic Cancer (STAR_PAC)

Who this might be right for
Pancreatic Adenocarcinoma
Barts & The London NHS Trust 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04482309
What this trial is testing

T-DXd in Patients With Selected HER2 Expressing Tumors

Who this might be right for
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca 477
Not applicableNot Yet RecruitingNCT06167421
What this trial is testing

Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy

Who this might be right for
Pancreatic Tumor, BenignPancreatic Neuroendocrine TumorSolid Pseudopapillary Tumor of the Pancreas
Fudan University 240
Not applicableUnknownNCT03809247
What this trial is testing

Microbial Diversity of Pancreatic Diseases

Who this might be right for
Pancreatic CancerPancreatic Disease
Ruijin Hospital 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363
What this trial is testing

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tang-Du Hospital 37
Testing effectiveness (Phase 2)Study completedNCT01978184
What this trial is testing

Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine

Who this might be right for
Pancreatic Cancer
Nathan Bahary, MD 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Not applicableLooking for participantsNCT05914987
What this trial is testing

Determining Individualized Cancer Therapy in Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Medical College of Wisconsin 1,000
Not applicableNo Longer AvailableNCT04137822
What this trial is testing

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreatic CancerPancreatic Cancer Stage IV+1 more
Impatients N.V. trading as myTomorrows
Testing effectiveness (Phase 2)Study completedNCT02549937
What this trial is testing

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Hutchmed 130
Not applicableStudy completedNCT03187028
What this trial is testing

Diet and Exercise After Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Alabama at Birmingham 15
Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Early research (Phase 1)Ended earlyNCT00783172
What this trial is testing

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Milton S. Hershey Medical Center 4
Large-scale testing (Phase 3)Ended earlyNCT01956812
What this trial is testing

Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic Cancer
Gilead Sciences 334
Testing effectiveness (Phase 2)UnknownNCT03662412
What this trial is testing

Study of Sirolimus in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Early research (Phase 1)Looking for participantsNCT06673329
What this trial is testing

Brodalumab in the Treatment of Immune-Related Adverse Events

Who this might be right for
Breast CancerEsophageal CancerKidney Cancer+15 more
Brian Henick, MD 11
Large-scale testing (Phase 3)UnknownNCT02854072
What this trial is testing

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Samsung Pharmaceutical Co., Ltd. 148
Next Page